Tag Archives: trial

NIH ‘very concerned’ about serious side effect in AstraZeneca coronavirus vaccine trial

“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »

ESC: Eli Lilly, Boehringer’s Jardiance cuts CV events by 25% in Farxiga-matching heart failure trial

AstraZeneca put the rest of the SGLT2 inhibitor class on notice when its Farxiga scored an FDA heart failure nod in patients with or without diabetes. One of its competitors, Eli Lilly and Boehringer Ingelheim’s Jardiance, is fast on Farxiga’s heels, though, and it’s ready to bring its pivotal trial win in front of physicians.  Jardiance, added… Read More »

Coronavirus vaccines: ‘Encouraging’ early data for some, a trial delay for another and more research ahead

According to the World Health Organization, there are 18 candidate vaccines in clinical evaluation globally. Researchers at University of Oxford said this week they have vaccinated 8,000 people in the UK as part of a Phase 3 trial. Yet there are still major hurdles to jump and more work to be done. No vaccines have… Read More »